{"product_id":"txr-1g-iv-inj-txr-500mg-im-inj-txr-500mg-iv-inj-txr-inj-2g-iv","title":"TXR 1G IV INJ TXR 500MG IM INJ TXR 500MG IV INJ TXR INJ 2G IV","description":"\u003cdiv class=\"container\"\u003e\r\\n\u003cdiv id=\"model-response-message-contentr_8819068ba3e6664c\" class=\"markdown markdown-main-panel md-content animate enable-luminous-fast-follows enable-updated-hr-color tutor-markdown-rendering\" dir=\"ltr\" aria-busy=\"true\" aria-live=\"polite\"\u003e\r\\n\u003ch2 data-path-to-node=\"11\"\u003eProduct Overview\u003c\/h2\u003e\r\\n\u003cp data-path-to-node=\"12\"\u003e\u003cb data-path-to-node=\"12\" data-index-in-node=\"0\"\u003eTXR Injection\u003c\/b\u003e is a broad-spectrum, long-acting parenteral third-generation cephalosporin antibiotic containing \u003cb data-path-to-node=\"12\" data-index-in-node=\"111\"\u003eCeftriaxone Sodium\u003c\/b\u003e. Engineered for immediate systemic bioavailability via Intravenous (IV) injection\/infusion or Intramuscular (IM) injection, TXR delivers potent bactericidal action against a comprehensive range of Gram-negative and Gram-positive aerobic and anaerobic bacterial pathogens. It is widely indicated for severe lower respiratory tract infections, bacterial meningitis, intra-abdominal infections, complicated urinary tract infections, bone and joint infections, pelvic inflammatory disease, skin\/soft tissue infections, bacterial septicemia, and surgical infection prophylaxis.\u003c\/p\u003e\r\\n\r\\n\u003ch3 data-path-to-node=\"13\"\u003eKey Benefits\u003c\/h3\u003e\r\\n\u003cul data-path-to-node=\"14\"\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"14,0,0\"\u003e\u003cb data-path-to-node=\"14,0,0\" data-index-in-node=\"0\"\u003eBroad-Spectrum Bactericidal Coverage:\u003c\/b\u003e Highly effective against resistant Gram-negative bacilli (including \u003ci data-path-to-node=\"14,0,0\" data-index-in-node=\"106\"\u003eEnterobacteriaceae\u003c\/i\u003e and \u003ci data-path-to-node=\"14,0,0\" data-index-in-node=\"129\"\u003eHaemophilus influenzae\u003c\/i\u003e) and Gram-positive pathogens (\u003ci data-path-to-node=\"14,0,0\" data-index-in-node=\"182\"\u003eStreptococcus pneumoniae\u003c\/i\u003e).\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"14,1,0\"\u003e\u003cb data-path-to-node=\"14,1,0\" data-index-in-node=\"0\"\u003eExtended Systemic Half-Life:\u003c\/b\u003e Features a prolonged elimination half-life that permits convenient \u003cb data-path-to-node=\"14,1,0\" data-index-in-node=\"96\"\u003eonce-daily\u003c\/b\u003e parenteral administration in most clinical indications.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"14,2,0\"\u003e\u003cb data-path-to-node=\"14,2,0\" data-index-in-node=\"0\"\u003eHigh Meningeal Penetration:\u003c\/b\u003e Crosses inflamed blood-brain barriers rapidly, serving as a primary line of treatment for bacterial meningitis.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"14,3,0\"\u003e\u003cb data-path-to-node=\"14,3,0\" data-index-in-node=\"0\"\u003eDual Route \u0026amp; Flexible Dosing (500mg to 2g):\u003c\/b\u003e Offered in specific IV and IM formulations across 500mg, 1g, and 2g strengths to cater to pediatric, adult, and critical inpatient care.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"14,4,0\"\u003e\u003cb data-path-to-node=\"14,4,0\" data-index-in-node=\"0\"\u003eSurgical Infection Prophylaxis:\u003c\/b\u003e Effective single-dose pre-operative prophylaxis to prevent post-operative surgical site infections.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n\u003c\/ul\u003e\r\\n\u003ch3 data-path-to-node=\"15\"\u003eHow It Works\u003c\/h3\u003e\r\\n\u003cp data-path-to-node=\"16\"\u003eTXR Injection (Ceftriaxone Sodium) exerts its bactericidal action by selectively binding to \u003cb data-path-to-node=\"16\" data-index-in-node=\"92\"\u003epenicillin-binding proteins (PBPs)\u003c\/b\u003e located on the inner bacterial cell membrane. This binding blocks the final transpeptidation step of peptidoglycan synthesis, disrupting the structural assembly of the bacterial cell wall. The resulting osmotic instability triggers cell wall rupture, autolytic enzyme activation, and rapid cell death of dividing bacterial organisms.\u003c\/p\u003e\r\\n\r\\n\u003ch2 data-path-to-node=\"18\"\u003eWooCommerce Attribute \/ Variation Details\u003c\/h2\u003e\r\\n\u003ch3 data-path-to-node=\"19\"\u003eVariation 1: TXR 500MG IM INJ\u003c\/h3\u003e\r\\n\u003cul data-path-to-node=\"20\"\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"20,0,0\"\u003e\u003cb data-path-to-node=\"20,0,0\" data-index-in-node=\"0\"\u003eSKU:\u003c\/b\u003e \u003ccode data-path-to-node=\"20,0,0\" data-index-in-node=\"5\"\u003eTXR-INJ-500-IM\u003c\/code\u003e\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"20,1,0\"\u003e\u003cb data-path-to-node=\"20,1,0\" data-index-in-node=\"0\"\u003eShort Description:\u003c\/b\u003e Formulated specifically for deep intramuscular administration; ideal for pediatric outpatient care, uncomplicated gonorrhea, and mild-to-moderate community infections.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"20,2,0\"\u003e\u003cb data-path-to-node=\"20,2,0\" data-index-in-node=\"0\"\u003eKey Active Ingredient:\u003c\/b\u003e Ceftriaxone Sodium — equivalent to 500mg Ceftriaxone per vial (reconstituted with Lidocaine Hydrochloride solution to minimize injection site pain).\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"20,3,0\"\u003e\u003cb data-path-to-node=\"20,3,0\" data-index-in-node=\"0\"\u003eTarget Indications:\u003c\/b\u003e Uncomplicated gonococcal infections, pediatric mild-to-moderate respiratory\/urinary infections, and acute otitis media.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"20,4,0\"\u003e\u003cb data-path-to-node=\"20,4,0\" data-index-in-node=\"0\"\u003eStandard Dosage:\u003c\/b\u003e Administer 500mg deeply into a large muscle mass once daily, or as prescribed by a healthcare provider.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n\u003c\/ul\u003e\r\\n\u003ch3 data-path-to-node=\"21\"\u003eVariation 2: TXR 500MG IV INJ\u003c\/h3\u003e\r\\n\u003cul data-path-to-node=\"22\"\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"22,0,0\"\u003e\u003cb data-path-to-node=\"22,0,0\" data-index-in-node=\"0\"\u003eSKU:\u003c\/b\u003e \u003ccode data-path-to-node=\"22,0,0\" data-index-in-node=\"5\"\u003eTXR-INJ-500-IV\u003c\/code\u003e\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"22,1,0\"\u003e\u003cb data-path-to-node=\"22,1,0\" data-index-in-node=\"0\"\u003eShort Description:\u003c\/b\u003e Intravenous formulation intended for pediatric inpatient care, step-down parenteral therapy, and moderate systemic infections.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"22,2,0\"\u003e\u003cb data-path-to-node=\"22,2,0\" data-index-in-node=\"0\"\u003eKey Active Ingredient:\u003c\/b\u003e Ceftriaxone Sodium — equivalent to 500mg Ceftriaxone per vial (reconstituted with Sterile Water for Injection).\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"22,3,0\"\u003e\u003cb data-path-to-node=\"22,3,0\" data-index-in-node=\"0\"\u003eTarget Indications:\u003c\/b\u003e Pediatric systemic infections, complicated UTI, and moderate lower respiratory tract infections.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"22,4,0\"\u003e\u003cb data-path-to-node=\"22,4,0\" data-index-in-node=\"0\"\u003eStandard Dosage:\u003c\/b\u003e Administer 500mg slowly via direct IV injection over 2 to 4 minutes once daily.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n\u003c\/ul\u003e\r\\n\u003ch3 data-path-to-node=\"23\"\u003eVariation 3: TXR 1G IV INJ\u003c\/h3\u003e\r\\n\u003cul data-path-to-node=\"24\"\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"24,0,0\"\u003e\u003cb data-path-to-node=\"24,0,0\" data-index-in-node=\"0\"\u003eSKU:\u003c\/b\u003e \u003ccode data-path-to-node=\"24,0,0\" data-index-in-node=\"5\"\u003eTXR-INJ-1G-IV\u003c\/code\u003e\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"24,1,0\"\u003e\u003cb data-path-to-node=\"24,1,0\" data-index-in-node=\"0\"\u003eShort Description:\u003c\/b\u003e Standard adult intravenous strength for severe community-acquired infections, pre-operative surgical prophylaxis, and inpatient care.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"24,2,0\"\u003e\u003cb data-path-to-node=\"24,2,0\" data-index-in-node=\"0\"\u003eKey Active Ingredient:\u003c\/b\u003e Ceftriaxone Sodium — equivalent to 1g Ceftriaxone per vial.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"24,3,0\"\u003e\u003cb data-path-to-node=\"24,3,0\" data-index-in-node=\"0\"\u003eTarget Indications:\u003c\/b\u003e Community-acquired pneumonia, acute pyelonephritis, intra-abdominal infections, skin\/soft tissue infections, and perioperative prophylaxis.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"24,4,0\"\u003e\u003cb data-path-to-node=\"24,4,0\" data-index-in-node=\"0\"\u003eStandard Dosage:\u003c\/b\u003e Administer 1g to 2g intravenously once daily (or 1g IV given 30 to 90 minutes prior to surgery).\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n\u003c\/ul\u003e\r\\n\u003ch3 data-path-to-node=\"25\"\u003eVariation 4: TXR INJ 2G IV\u003c\/h3\u003e\r\\n\u003cul data-path-to-node=\"26\"\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"26,0,0\"\u003e\u003cb data-path-to-node=\"26,0,0\" data-index-in-node=\"0\"\u003eSKU:\u003c\/b\u003e \u003ccode data-path-to-node=\"26,0,0\" data-index-in-node=\"5\"\u003eTXR-INJ-2G-IV\u003c\/code\u003e\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"26,1,0\"\u003e\u003cb data-path-to-node=\"26,1,0\" data-index-in-node=\"0\"\u003eShort Description:\u003c\/b\u003e High-potency intravenous strength reserved for critical inpatient care, severe bacterial meningitis, and life-threatening septicemia.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"26,2,0\"\u003e\u003cb data-path-to-node=\"26,2,0\" data-index-in-node=\"0\"\u003eKey Active Ingredient:\u003c\/b\u003e Ceftriaxone Sodium — equivalent to 2g Ceftriaxone per vial.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"26,3,0\"\u003e\u003cb data-path-to-node=\"26,3,0\" data-index-in-node=\"0\"\u003eTarget Indications:\u003c\/b\u003e Bacterial meningitis, severe hospital-acquired septicemia, neutropenic fever, and severe bone and joint infections.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"26,4,0\"\u003e\u003cb data-path-to-node=\"26,4,0\" data-index-in-node=\"0\"\u003eStandard Dosage:\u003c\/b\u003e Administer 2g once daily (or 2g every 12 hours for bacterial meningitis) via slow IV infusion over 30 minutes.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n\u003c\/ul\u003e\r\\n\u003ch2 data-path-to-node=\"28\"\u003eGeneral Product Details (Shared across variations)\u003c\/h2\u003e\r\\n\u003ch3 data-path-to-node=\"29\"\u003eKey Active Ingredients\u003c\/h3\u003e\r\\n\u003cul data-path-to-node=\"30\"\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"30,0,0\"\u003e\u003cb data-path-to-node=\"30,0,0\" data-index-in-node=\"0\"\u003eCeftriaxone Sodium (500mg \/ 1g \/ 2g):\u003c\/b\u003e Parenteral third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n\u003c\/ul\u003e\r\\n\u003ch3 data-path-to-node=\"31\"\u003eDirections for Use\u003c\/h3\u003e\r\\n\u003col start=\"1\" data-path-to-node=\"32\"\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp class=\"animating\" data-path-to-node=\"32,0,0\"\u003e\u003cb class=\"animating\" data-path-to-node=\"32,0,0\" data-index-in-node=\"0\"\u003eReconstitution:\u003c\/b\u003e\u003c\/p\u003e\r\\n\r\\n\u003cul class=\"animating\" data-path-to-node=\"32,0,1\"\u003e\r\\n \t\u003cli class=\"animating\"\u003e\r\\n\u003cp class=\"animating\" data-path-to-node=\"32,0,1,0,0\"\u003e\u003cb class=\"animating\" data-path-to-node=\"32,0,1,0,0\" data-index-in-node=\"0\"\u003eFor IM Route (TXR 500mg IM):\u003c\/b\u003e\u003cspan class=\"animating\"\u003e Reconstitute strictly with \u003c\/span\u003e\u003cb class=\"animating\" data-path-to-node=\"32,0,1,0,0\" data-index-in-node=\"56\"\u003e1% Lidocaine Hydrochloride solution\u003c\/b\u003e\u003cspan class=\"animating\"\u003e to reduce local injection pain.\u003c\/span\u003e \u003ci class=\"animating\" data-path-to-node=\"32,0,1,0,0\" data-index-in-node=\"124\"\u003eWarning: Solutions containing Lidocaine must NEVER be administered intravenously.\u003c\/i\u003e\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"32,0,1,1,0\"\u003e\u003cb data-path-to-node=\"32,0,1,1,0\" data-index-in-node=\"0\"\u003eFor IV Route (TXR 500mg IV, 1g IV, 2g IV):\u003c\/b\u003e Reconstitute with Sterile Water for Injection or 0.9% Sodium Chloride Injection. For IV infusion (1g\/2g), dilute reconstituted solution further in 50ml to 100ml of compatible IV fluids (0.9% Normal Saline or 5% Dextrose).\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n\u003c\/ul\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"32,1,0\"\u003e\u003cb data-path-to-node=\"32,1,0\" data-index-in-node=\"0\"\u003eAdministration:\u003c\/b\u003e\u003c\/p\u003e\r\\n\r\\n\u003cul data-path-to-node=\"32,1,1\"\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"32,1,1,0,0\"\u003e\u003cb data-path-to-node=\"32,1,1,0,0\" data-index-in-node=\"0\"\u003eDirect IV Injection:\u003c\/b\u003e Administer slowly over 2 to 4 minutes.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"32,1,1,1,0\"\u003e\u003cb data-path-to-node=\"32,1,1,1,0\" data-index-in-node=\"0\"\u003eIV Infusion:\u003c\/b\u003e Infuse over at least 30 minutes.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"32,1,1,2,0\"\u003e\u003cb data-path-to-node=\"32,1,1,2,0\" data-index-in-node=\"0\"\u003eIM Injection:\u003c\/b\u003e Administer via deep intramuscular injection into a large muscle mass (gluteal region).\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n\u003c\/ul\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"32,2,0\"\u003e\u003cb data-path-to-node=\"32,2,0\" data-index-in-node=\"0\"\u003eCalcium Compatibility Warning:\u003c\/b\u003e Do \u003cb data-path-to-node=\"32,2,0\" data-index-in-node=\"34\"\u003eNOT\u003c\/b\u003e mix or administer Ceftriaxone simultaneously with calcium-containing IV solutions (such as Ringer's or Hartman's solution), as precipitation may occur.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"32,3,0\"\u003e\u003cb data-path-to-node=\"32,3,0\" data-index-in-node=\"0\"\u003eProfessional Healthcare Use:\u003c\/b\u003e Must be administered exclusively by qualified medical personnel in a clinical or hospital setting.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n\u003c\/ol\u003e\r\\n\u003ch3 data-path-to-node=\"33\"\u003ePrecautions\u003c\/h3\u003e\r\\n\u003cul data-path-to-node=\"34\"\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"34,0,0\"\u003e\u003cb data-path-to-node=\"34,0,0\" data-index-in-node=\"0\"\u003ePrescription-Only Parenteral:\u003c\/b\u003e Strictly for professional healthcare administration; do not self-administer.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"34,1,0\"\u003e\u003cb data-path-to-node=\"34,1,0\" data-index-in-node=\"0\"\u003eHypersensitivity Alert:\u003c\/b\u003e Carefully screen patients for prior severe hypersensitivity reactions to cephalosporins, penicillins, or other beta-lactam antibiotics.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"34,2,0\"\u003e\u003cb data-path-to-node=\"34,2,0\" data-index-in-node=\"0\"\u003eHyperbilirubinemic Neonates:\u003c\/b\u003e Contraindicated in hyperbilirubinemic neonates and premature infants due to the risk of bilirubin encephalopathy.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"34,3,0\"\u003e\u003cb data-path-to-node=\"34,3,0\" data-index-in-node=\"0\"\u003eGallbladder \u0026amp; Renal Sludging:\u003c\/b\u003e High-dose or prolonged therapy may cause transient gallbladder biliary sludging or renal precipitates; monitor accordingly.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"34,4,0\"\u003eConsult an attending physician before use during pregnancy or lactation.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"34,5,0\"\u003eKeep out of reach of children.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n\u003c\/ul\u003e\r\\n\u003ch3 data-path-to-node=\"35\"\u003eStorage Instructions\u003c\/h3\u003e\r\\n\u003cp data-path-to-node=\"36\"\u003eStore the un-reconstituted dry powder vial in a cool, dry place below 30°C, protected from direct sunlight and heat. Once reconstituted, solutions remain stable for up to 6 hours at room temperature (\u003cspan class=\"math-inline\" data-math=\"25^\\circ\\text{C}\" data-index-in-node=\"200\"\u003e\u003cspan class=\"katex\"\u003e\u003cspan class=\"katex-html\" aria-hidden=\"true\"\u003e\u003cspan class=\"base\"\u003e\u003cspan class=\"mord\"\u003e2\u003c\/span\u003e\u003cspan class=\"mord\"\u003e5\u003cspan class=\"msupsub\"\u003e\u003cspan class=\"vlist-t\"\u003e\u003cspan class=\"vlist-r\"\u003e\u003cspan class=\"vlist\"\u003e\u003cspan class=\"\"\u003e\u003cspan class=\"sizing reset-size6 size3 mtight\"\u003e\u003cspan class=\"mbin mtight\"\u003e∘\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cspan class=\"mord text\"\u003e\u003cspan class=\"mord\"\u003eC\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e) or up to 24 hours under refrigeration (\u003cspan class=\"math-inline\" data-math=\"2^\\circ\\text{C}\" data-index-in-node=\"257\"\u003e\u003cspan class=\"katex\"\u003e\u003cspan class=\"katex-html\" aria-hidden=\"true\"\u003e\u003cspan class=\"base\"\u003e\u003cspan class=\"mord\"\u003e2\u003cspan class=\"msupsub\"\u003e\u003cspan class=\"vlist-t\"\u003e\u003cspan class=\"vlist-r\"\u003e\u003cspan class=\"vlist\"\u003e\u003cspan class=\"\"\u003e\u003cspan class=\"sizing reset-size6 size3 mtight\"\u003e\u003cspan class=\"mbin mtight\"\u003e∘\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cspan class=\"mord text\"\u003e\u003cspan class=\"mord\"\u003eC\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e to \u003cspan class=\"math-inline\" data-math=\"8^\\circ\\text{C}\" data-index-in-node=\"276\"\u003e\u003cspan class=\"katex\"\u003e\u003cspan class=\"katex-html\" aria-hidden=\"true\"\u003e\u003cspan class=\"base\"\u003e\u003cspan class=\"mord\"\u003e8\u003cspan class=\"msupsub\"\u003e\u003cspan class=\"vlist-t\"\u003e\u003cspan class=\"vlist-r\"\u003e\u003cspan class=\"vlist\"\u003e\u003cspan class=\"\"\u003e\u003cspan class=\"sizing reset-size6 size3 mtight\"\u003e\u003cspan class=\"mbin mtight\"\u003e∘\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cspan class=\"mord text\"\u003e\u003cspan class=\"mord\"\u003eC\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e). Do not freeze.\u003c\/p\u003e\r\\n\r\\n\u003ch3 data-path-to-node=\"37\"\u003eManufacturer Information\u003c\/h3\u003e\r\\n\u003cp data-path-to-node=\"38\"\u003eFormulated and manufactured in strict compliance with international pharmaceutical quality standards, dedicated to providing high-potency anti-infective parenteral formulations that combat multi-drug resistant pathogens and support critical inpatient recovery.\u003c\/p\u003e\r\\n\r\\n\u003c\/div\u003e\r\\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":44164490854459,"sku":null,"price":0.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0695\/4899\/8715\/files\/TXR-1G.jpg?v=1789027892","url":"https:\/\/pharmaservicesgroup.com\/products\/txr-1g-iv-inj-txr-500mg-im-inj-txr-500mg-iv-inj-txr-inj-2g-iv","provider":"Pharma Services Distribution","version":"1.0","type":"link"}